European Journal of Haematology

Is TCL1 overexpression a good or a bad player in mantle cell lymphoma?
pp. 487-488(2)
Authors: Bea, Silvia; Matutes, Estella

Management of intermediate‐risk pulmonary embolism: uncertainties and challenges
pp. 489-497(9)
Authors: Klok, Frederikus Albertus; Meyer, Guy; Konstantinides, Stavros

Allogeneic stem cell transplantation for refractory acute myeloid leukemia: a single center analysis of long‐term outcome
pp. 498-506(9)
Authors: Hemmati, Philipp G.; Terwey, Theis H.; Na, Il‐Kang; Jehn, Christian F.; Coutre, Philipp; Vuong, Lam G.; Dörken, Bernd; Arnold, Renate

Hepcidin‐25 vs. conventional clinical biomarkers in the diagnosis of functional iron deficiency
pp. 507-513(7)
Authors: Enko, Dietmar; Wagner, Helga; Kriegshäuser, Gernot; Kimbacher, Christine; Stolba, Robert; Worf, Elfriede; Halwachs‐Baumann, Gabriele

Effect of ATG‐F on B‐cell reconstitution after hematopoietic stem cell transplantation
pp. 514-523(10)
Authors: Roll, Petra; Muhammad, Khalid; Stuhler, Gernot; Grigoleit, Ulrich; Einsele, Hermann; Tony, Hans‐Peter

Molecular changes associated with the development of resistance to imatinib in an imatinib‐sensitive canine neoplastic mast cell line carrying a KIT c.1523A>T mutation
pp. 524-531(8)
Authors: Kobayashi, Masato; Kuroki, Shiori; Tanaka, Yu; Moriya, Yukari; Kozutumi, Yukari; Uehara, Yuji; Ono, Kenichiro; Tamura, Kyoichi; Washizu, Tsukimi; Bonkobara, Makoto

Antibody binding to megakaryocytes in vivo in patients with immune thrombocytopenia
pp. 532-537(6)
Authors: Arnold, Donald M; Nazi, Ishac; Toltl, Lisa J; Ross, Catherine; Ivetic, Nikola; Smith, James W; Liu, Yang; Kelton, John G

The significance of pretreatment anemia in the era of R‐IPI and NCCN‐IPI prognostic risk assessment tools: a dual‐center study in diffuse large B‐cell lymphoma patients
pp. 538-544(7)
Authors: Troppan, Katharina T.; Melchardt, Thomas; Deutsch, Alexander; Schlick, Konstantin; Stojakovic, Tatjana; Bullock, Marc D.; Reitz, Daniel; Beham‐Schmid, Christine; Weiss, Lukas; Neureiter, Daniel; Wenzl, Kerstin; Greil, Richard; Neumeister, Peter; Egle, Alexander; Pichler, Martin

Deferasirox in patients with iron overload secondary to hereditary hemochromatosis: results of a 1‐yr Phase 2 study
pp. 545-550(6)
Authors: Cançado, Rodolfo; Melo, Murilo R.; Moraes Bastos, Roberto; Santos, Paulo C. J. L.; Guerra‐Shinohara, Elivira M.; Chiattone, Carlos; Ballas, Samir K.

Differences in Aspergillus‐specific immune recovery between T‐cell‐replete and T‐cell‐depleted hematopoietic transplants
pp. 551-557(7)
Authors: Perruccio, Katia; Topini, Fabiana; Tosti, Antonella; Gazzola, Maria Vittoria; Messina, Chiara; Martelli, Massimo F.; Caniglia, Maurizio; Velardi, Andrea; Cesaro, Simone

A prospective analysis of clinical efficacy and safety in chronic myeloid leukemia‐chronic phase patients with imatinib resistance or intolerance as evaluated using European LeukemiaNet 2013 criteria
pp. 558-565(8)
Authors: Murai, Kazunori; Akagi, Tomoaki; Shimosegawa, Kenji; Sugawara, Tomohiro; Ishizawa, Kenichi; Ito, Shigeki; Murai, Keiko; Motegi, Mutsuhito; Yokoyama, Hisayuki; Noji, Hideyoshi; Tajima, Katsushi; Kimura, Jun; Chou, Takaaki; Ogawa, Kazuei; Harigae, Hideo; Kubo, Kohmei; Oba, Koji; Sakamoto, Junichi; Ishida, Yoji

Reduced DNA methylation and hydroxymethylation in patients with systemic mastocytosis
pp. 566-575(10)
Authors: Leoni, Cristina; Montagner, Sara; Deho', Lorenzo; D'Antuono, Rocco; De Matteis, Giovanna; Marzano, Angelo V.; Merante, Serena; Orlandi, Ester M.; Zanotti, Roberta; Monticelli, Silvia

Feasibility and efficacy of outpatient therapy with intermediate dose cytarabine, fludarabine and idarubicin for patients with acute myeloid leukaemia aged 70 or older
pp. 576-582(7)
Authors: Vives, Susana; Oriol, Albert; Piernas, Sònia; Brunet, Salut; Clapés, Victòria; Guardia, Ramon; Subirà, Maricel; Sierra, Jordi; Ribera, Josep‐Maria; the CETLAM Groupejh12538-cr-0010

TCL1 expression predicts overall survival in patients with mantle cell lymphoma
pp. 583-594(12)
Authors: Shin, Su‐Jin; Roh, Jin; Cha, Hee Jeong; Choi, Yoo Duk; Kim, Jin‐Man; Min, Soo Kee; Kim, Ji Eun; Eom, Dae‐Woon; Lee, Hojung; Kim, Hyun‐Jung; Yoon, Dok Hyun; Suh, Cheolwon; Huh, Jooryung

Successful treatment of mast cell activation syndrome with sunitinib
pp. 595-597(3)
Authors: Afrin, Lawrence B.; Cichocki, Frank M.; Patel, Kamal; Molderings, Gerhard J.